Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma

International Journal of Gynecological Pathology

Volumn 25, Issue 2, 2006, Pages 121-130

  Köbel, Martin ^a   Gradhand, Elise ^a   Zeng, Katharina ^a   Schmitt, Wolfgang D ^a   Kriese, Karen ^a   Lantzsch, Tilmann ^b   Wolters, Matthias ^c   Dittmer, Jürgen ^a   Strauss, Hans G ^a   Thomssen, Christoph ^a   Hauptmann, Steffen ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Krankenhaus St Elisabeth und St Barbara   (Germany)

^c Carl von Basedow Clinic   (Germany)

Author keywords

Expression; Ezrin; Ovarian carcinoma; Prognosis

Indexed keywords

CARBOPLATIN; EZRIN; MOESIN; PACLITAXEL; PLATINUM; ACTIN BINDING PROTEIN; CYTOSKELETON PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; RNA INTERFERENCE; UNIVARIATE ANALYSIS; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; METABOLISM; MULTIVARIATE ANALYSIS; OVARY TUMOR; PATHOLOGY; SURVIVAL; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RISK FACTORS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 33747169628     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000185410.39050.ac     Document Type: Article

References (21)

1. Cannistra SA, Kansas GS, Niloff J, et al. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res 1993;53:3830-8.
2. Sillanpaa S, Anttila MA, Voutilainen K, et al. CD44 expression indicates favorable prognosis in epithelial ovarian cancer. Clin Cancer Res 2003;9:5318-24.
3. Rodriguez-Rodriguez L, Sancho-Torres I, Mesonero C, et al. The CD44 receptor is a molecular predictor of survival in ovarian cancer. Med Oncol 2003;20:255-63.
4. Mangeat P, Roy C, Martin M. ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol 1999;9:187-92.
5. Ohtani K, Sakamoto H, Rutherford T, et al. Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma. Cancer Lett 2002;179:79-86.
6. Akisawa N, Nishimori I, Iwamura T, et al. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 1999;258:395-400.
7. Ichikawa T, Masumoto J, Kaneko M, et al. Expression of moesin and its associated molecule CD44 in epithelial skin tumors. J Cutan Pathol 1998;25:237-43.
8. Kobayashi H, Sagara J, Masumoto J. et al. Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma. J Oral Pathol Med 2003;32:344-9.
9. Makitie T, Carpen O, Vaheri A, et al. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci 2001;42:2442-9.
10. Geiger KD, Stoldt P, Schlote W, et al. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 2000;157:1785-93.
11. Chen Z, Fadiel A, Feng Y, et al. Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor. Cancer 2001;92:3068-75.
12. Moilanen J, Lassus H, Leminen A, et al. Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol Oncol 2003;90:273-81.
13. Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 2000;19:7-15.
14. Kobel M, Weichert W, Cruwell K, et al. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch 2004;445:456-64.
15. Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002;26:199-213.
16. Heldin P, Pertoft H. Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp Cell Res 1993;208:422-9.
17. Schroder W, Rudlowski C, Biesterfeld S, et al. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases. Anticancer Res 1999;19:3901-6.
18. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol 2001;25:419-32.
19. Shih I, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004;164:1511-8.
20. Mackay DJ, Esch F, Furthmayr H, et al. Rho-and rac-dependent assembly of focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential role for ezrin/radixin/ moesin proteins. J Cell Biol 1997;138:927-38.
21. Gautreau A, Poullet P, Louvard D, et al. Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 1999;96:7300-5.